Charles Eby

3.9k total citations · 1 hit paper
36 papers, 2.4k citations indexed

About

Charles Eby is a scholar working on Pharmacology, Hematology and Surgery. According to data from OpenAlex, Charles Eby has authored 36 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 11 papers in Hematology and 6 papers in Surgery. Recurrent topics in Charles Eby's work include Pharmacogenetics and Drug Metabolism (12 papers), Platelet Disorders and Treatments (7 papers) and Hormonal Regulation and Hypertension (6 papers). Charles Eby is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Platelet Disorders and Treatments (7 papers) and Hormonal Regulation and Hypertension (6 papers). Charles Eby collaborates with scholars based in United States, Italy and Canada. Charles Eby's co-authors include Brian F. Gage, Paul E. Milligan, Howard L. McLeod, Deepak Voora, George J. Despotis, Douglas M. Lublin, Leonard Grosso, Taimour Langaee, Elena Deych and Gloria R. Grice and has published in prestigious journals such as Blood, Clinical Chemistry and American Journal of Preventive Medicine.

In The Last Decade

Charles Eby

35 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

2008 595 citations Brian F. Gage, Charles Eby et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Eby United States	19	1.5k	609	478	323	314	36	2.4k
Patrick Kesteven United Kingdom	19	1.9k 1.3×	772 1.3×	944 2.0×	440 1.4×	140 0.4×	51	3.4k
Deepak Voora United States	27	1.5k 1.0×	609 1.0×	802 1.7×	211 0.7×	105 0.3×	102	3.6k
Andrea Jorgensen United Kingdom	32	1.4k 1.0×	405 0.7×	509 1.1×	162 0.5×	113 0.4×	107	3.7k
Niclas Eriksson Sweden	23	2.1k 1.4×	856 1.4×	1.2k 2.6×	397 1.2×	123 0.4×	67	4.2k
Roberto Padrini Italy	27	646 0.4×	275 0.5×	503 1.1×	145 0.4×	419 1.3×	104	2.7k
Paul E. Milligan United States	18	1.3k 0.9×	527 0.9×	1.2k 2.6×	252 0.8×	62 0.2×	31	2.6k
Hilary Wynne United Kingdom	28	1.5k 1.0×	551 0.9×	690 1.4×	310 1.0×	38 0.1×	76	3.5k
Larisa H. Cavallari United States	40	3.1k 2.1×	861 1.4×	1.3k 2.7×	289 0.9×	111 0.4×	198	5.3k
Edith A. Nutescu United States	34	1.1k 0.8×	364 0.6×	2.0k 4.3×	171 0.5×	432 1.4×	186	4.2k
Jonatan D. Lindh Sweden	26	1.3k 0.9×	556 0.9×	419 0.9×	209 0.6×	33 0.1×	83	2.9k

Countries citing papers authored by Charles Eby

Since Specialization

Citations

This map shows the geographic impact of Charles Eby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Eby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Eby more than expected).

Fields of papers citing papers by Charles Eby

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Eby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Eby. The network helps show where Charles Eby may publish in the future.

Co-authorship network of co-authors of Charles Eby

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Eby. A scholar is included among the top collaborators of Charles Eby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Eby. Charles Eby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Eby, Charles, et al.. (2025). Comparison of 2 thromboelastography methods using patient and control samples. Research and Practice in Thrombosis and Haemostasis. 9(3). 102843–102843.

Friedman, Kenneth D., Dennis J. Dietzen, Charles Eby, et al.. (2024). Evaluation of an automated von Willebrand factor glycoprotein IbM activity assay compared with 3 alternative von Willebrand factor activity assays. Research and Practice in Thrombosis and Haemostasis. 8(4). 102422–102422. 2 indexed citations

Vesoulis, Zachary A., et al.. (2024). Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world data. Journal of Thrombosis and Haemostasis. 22(12). 3473–3478. 1 indexed citations

Deych, Elena, Paul E. Milligan, Charles Eby, et al.. (2010). Gamma-glutamyl carboxylase and its influence on warfarin dose. Thrombosis and Haemostasis. 104(10). 750–754. 45 indexed citations

Eby, Charles. (2009). Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias. British Journal of Haematology. 145(2). 151–163. 72 indexed citations

Nowalk, Mary Patricia, Chyongchiou J. Lin, Seth Toback, et al.. (2009). Improving Influenza Vaccination Rates in the Workplace. American Journal of Preventive Medicine. 38(3). 237–246. 57 indexed citations

Eby, Charles. (2009). Antiphospholipid Syndrome Review. Clinics in Laboratory Medicine. 29(2). 305–319. 10 indexed citations

Despotis, George J., Charles Eby, & Douglas M. Lublin. (2008). A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery. Transfusion. 48(s1). 2S–30S. 104 indexed citations

Gage, Brian F., Charles Eby, JA Johnson, et al.. (2008). Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin. Clinical Pharmacology & Therapeutics. 84(3). 326–331. 595 indexed citations breakdown →

10.

King, Cristi R., Rhonda Porche-Sorbet, Brian F. Gage, et al.. (2008). Performance of Commercial Platforms for Rapid Genotyping of Polymorphisms Affecting Warfarin Dose. American Journal of Clinical Pathology. 129(6). 876–883. 46 indexed citations

11.

Cunningham, Mark T., John T. Brandt, Wayne L. Chandler, et al.. (2007). Quality Assurance in Hemostasis: The Perspective from the College of American Pathologists Proficiency Testing Program. Seminars in Thrombosis and Hemostasis. 33(3). 250–258. 26 indexed citations

12.

Refaai, Majed A., et al.. (2006). Loss of Factor VIII and von Willebrand Factor Activities during Cold Storage of Whole Blood Is Reversed by Rewarming. PubMed. 12(2). 99–102. 17 indexed citations

13.

Hayes, Timothy E., John T. Brandt, Wayne L. Chandler, et al.. (2006). External Peer Review Quality Assurance Testing in von Willebrand Disease: The Recent Experience of the United States College of American Pathologists Proficiency Testing Program. Seminars in Thrombosis and Hemostasis. 32(5). 499–504. 33 indexed citations

14.

Eby, Charles, et al.. (2006). CLOTTING PROFILES AND SELECTED HEMATOLOGY OF CAPTIVE SPEKE'S GAZELLES (GAZELLA SPEKEI). Journal of Zoo and Wildlife Medicine. 37(1). 64–67. 9 indexed citations

15.

Voora, Deepak, Charles Eby, Mark W. Linder, et al.. (2005). Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype. Thrombosis and Haemostasis. 93(4). 700–705. 154 indexed citations

16.

Goodnough, Lawrence T., Douglas M. Lublin, Lini Zhang, George Despotis, & Charles Eby. (2004). Transfusion medicine service policies for recombinant factor VIIa administration. Transfusion. 44(9). 1325–1331. 97 indexed citations

17.

Voora, Deepak, Howard L. McLeod, Charles Eby, & Brian F. Gage. (2004). Use of pharmacogenetics to guide warfarin therapy. Drugs of today. 40(3). 247–247. 7 indexed citations

18.

Eby, Charles, et al.. (2003). Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin. Thrombosis and Haemostasis. 91(1). 87–94. 249 indexed citations

19.

Fuhrman, M. Patricia, et al.. (2000). Pancytopenia after Removal of Copper from Total Parenteral Nutrition. Journal of Parenteral and Enteral Nutrition. 24(6). 361–366. 72 indexed citations

20.

Silva, Marco Antônio Pereira da, James W. Edmondson, Charles Eby, & Patrick J. Loehrer. (1992). Humoral hypercalcemia in seminomas. Medical and Pediatric Oncology. 20(1). 38–41. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact